Back on Tip TV talking about Royal Mail, Pacific Biosciences and Actelion

Loyal readers might have been worried that Tip TV had given me the chop after several weeks without a clip being re-published on little old Betaville.

But fear not - I haven't been on the show because Tip TV have been moving studios. And today my old mucker Moose (aka Nick Batsford) invited me back for a sit down with man-about-town Zak Mir.

Nutmegged on SOBI

Hacks over at FT Alphaville have pulled the trigger on the Swedish Orphan Biovitrum takeover tale. Here is a link to the piece:

http://ftalphaville.ft.com/2016/05/20/2162592/friday-raw-are-bidders-circling-sobi-again/

Back on Tip TV talking about Sports Direct, Actelion and Swedish Orphan

It's a Monday, so here is a link to today's Tip TV session.

https://www.youtube.com/watch?v=zy4EamEaJOI

Another non-denial, denial

Today's wire reports out of Switzerland made me chuckle.

Apparently, Jean-Paul Clozel, chief executive of Actelion, told Reuters that "there's been absolutely no offer" to takeover the company.

Back on Tip TV talking about BP, Medivation and Actelion

I hadn't been on Tip TV for a while and was starting to wonder whether Moose, the owner of the channel, had got fed up with me.

Last week, though, I got the call inviting me on the show today, so here is the link:

Shire's next deal could be "transformational" - part 3

I have just returned from a jolly nice lunch with an investment banker chum to discover that Shire has launched a $30 billion hostile takeover for US rival Baxalta - wow!

Here is a link to the press release:

http://www.investegate.co.uk/shire-plc--shp-/prn/shire-proposes-combination-with-baxalta/20150804123000P8565/

RARE alert: Shire's next deal could be "transformational" - part 2

This (see below) well written interview with Shire chief executive Flemming Ornskov by the Wall Street Journal would appear to reinforce the idea that the FTSE 100-listed group is still on the hunt for a major acquisition - whether it be Actelion, BioMarin or another (US?) rival...

http://www.wsj.com/articles/shire-deepens-push-into-biotech-after-abbvie-drops-bid-1436821429?mod=pls_whats_news_us_business_f&utm_source=dlvr.it&utm_medium=twitter

Back on Tip TV talking about Mylan, Starwood Hotels and Shire/Actelion

It's a Monday, so here is the link to today's Tip TV session:

http://www.tiptv.co.uk/archives/ben-harrington/

Back on Tip TV talking about Actelion, Diageo and Vodafone

Zak Mir, the man who knows all about the Basque country, interviewed me on Tip TV this morning. Here is a link to today's show:

http://www.tiptv.co.uk/archives/actelion-diageo-and-vodafone-the-weekend-review/

Fancy that - Europe's biggest drug makers said to bid for InterMune

Oh look, I see Bloomberg and Reuters are both reporting that InterMune has attracted several suitors, including GlaxoSmithKline, Actelion, Roche and Sanofi:

http://www.bloomberg.com/news/2014-08-13/europe-s-biggest-drugmakers-said-to-bid-for-intermune.html

Another day, another multibillion dollar pharma deal....

Wow - today's news about Pfizer formally launching its $100 billion takeover bid for AstraZeneca has sent the pharmacuetical sector rumour mill into overdrive.

One company that is getting a lot of attention in European markets is US-based InterMune, a biotechnology business focused on the research and development of therapies in pulmonology and fibrotic diseases.